Skip to content

Clinical trials

Phase 4 Cognitive Dysfunction trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cognitive Dysfunction Phase: Phase 4 Country / region: China Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20102
20111
20151
20171
20192
20242
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status5
Recruiting4
Completed2
Not yet recruiting2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Dongzhimen Hospital, Beijing2
Chinese University of Hong Kong1
Dr. Willmar Schwabe GmbH & Co. KG1
First Affiliated Hospital of Wenzhou Medical University1
Fudan University1
Huazhong University of Science and Technology1
Ministry of Science and Technology of the People´s Republic of China1
Nanjing Medical University1
Peking Union Medical College Hospital1
Peking University First Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cognitive Dysfunction14
Cerebral Hemorrhage1
Cerebral Small Vessel Diseases1
Delirium1
Dementia1
Diabetes Mellitus, Type 21
Disease1
Epilepsies, Partial1
Intracranial Arteriosclerosis1
Ischemic Stroke1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.